Rehovot, Israel

Tamar Goren

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2001-2007

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tamar Goren: Innovator in Pharmaceutical Chemistry

Introduction

Tamar Goren is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various neurological disorders. With a total of 5 patents to her name, Goren's work is recognized for its potential impact on mental health treatments.

Latest Patents

One of Goren's latest patents focuses on aminoindan derivatives. This invention is directed to compounds that can be utilized for treating conditions such as depression, Attention Deficit Disorder (ADD), Attention Deficit and Hyperactivity Disorder (ADHD), Tourette's Syndrome, Alzheimer's Disease, and other forms of dementia. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of these compounds along with a pharmaceutically acceptable carrier.

Career Highlights

Throughout her career, Tamar Goren has worked with notable companies, including Teva Pharmaceutical Industries Limited. Her innovative research has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in mental health treatments.

Collaborations

Goren has collaborated with esteemed colleagues such as Michael Chorev and Jeffrey Sterling. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Tamar Goren's contributions to pharmaceutical chemistry, particularly through her innovative patents, highlight her role as a leading inventor in the industry. Her work continues to pave the way for new treatments for neurological disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…